1:10-cv-00007 | Cephalon Inc. et al v. Watson Laboratories Inc. | Jan 5, 2010 |
2:10-cv-00016 | Cephalon, Inc. et al v. Watson Pharmaceuticals, Inc. et al | Jan 7, 2010 |
1:10-cv-00055 | Cephalon Inc. et al v. Sandoz Inc. | Jan 22, 2010 |
1:10-cv-00175 | Cephalon, Inc. et al v. Sandoz Inc. | Jan 26, 2010 |
1:10-cv-00210 | Cephalon Inc. et al v. Lupin Limited et al | Mar 16, 2010 |
1:10-cv-00661 | Cephalon, Inc. et al v. Lupin Limited et al | Mar 17, 2010 |
1:10-cv-00695 | Cephalon Inc. et al v. Apotex Corp. et al | Aug 18, 2010 |
1:10-cv-22997 | Cephalon, Inc. et al v. Apotex Corp et al | Aug 19, 2010 |
1:10-md-02200 | In Re: Armodafinil Patent Litigation | Dec 8, 2010 |
1:10-cv-01078 | Cephalon, Inc. et al v. Apotex Corp et al | Dec 14, 2010 |
1:11-cv-00782 | Cephalon Inc. et al v. Sandoz Inc. | Sep 6, 2011 |
1:11-cv-01070 | Cephalon Inc. et al v. Breckenridge Pharmaceutical Inc. et al | Nov 2, 2011 |
2:11-cv-06455 | CEPHALON, INC. et al v. BRECKENRIDGE PHARMACEUTICAL, INC. et al | Nov 3, 2011 |
1:09-cv-00918 | Cephalon Inc. et al v. Teva Pharmaceuticals USA Inc. et al | Dec 2, 2009 |
1:09-cv-00940 | Cephalon Inc. et al v. Actavis Group et al | Dec 8, 2009 |
1:09-cv-00954 | Cephalon Inc. et al v. Mylan Pharmaceuticals Inc. | Dec 11, 2009 |
2:09-cv-06239 | CEPHALON, INC. et al v. ACTAVIS GROUP et al | Dec 10, 2009 |
1:12-cv-00248 | Cephalon Inc. v. Sandoz Inc. | Feb 29, 2012 |
1:15-cv-00117 | Cephalon Inc. et al v. Unimark Remedies Ltd. | Feb 2, 2015 |
1:15-cv-01044 | Cephalon Inc. et al v. Aurobindo Pharma Limited et al | Nov 12, 2015 |